Gilead Sciences signed licensing agreements with six generic manufacturers to increase access to lenacapavir for HIV prevention. But no, it will still not be...
The need for activism was stressed at International AIDS Conference 2024, or AIDS2024, with pharmaceutical companies in particular being pinpointed for prioritizing profit over...
If leaders take the bold actions needed now to ensure sufficient and sustainable resourcing and protect everyone’s human rights, the number of people living...
Early treatment is associated with a more rapid decay of genome-intact HIV, a decrease of genetic complexity across the reservoir, and prevents escape from...
The ex-chairperson of N+ detailed to Outrage Magazine the extent of his complaints. Former vice chair says new Board of Trustees being held accountable...